Molina Healthcare (NYSE:MOH) issued an update on its FY 2018 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $9.05-9.25 for the period, compared to the Thomson Reuters consensus estimate of $7.52. The company issued revenue guidance of $18.8-18.8 billion, compared to the consensus revenue estimate of $18.85 billion.Molina Healthcare also updated its FY18 guidance to $9.05-9.25 EPS.
Shares of MOH stock traded up $0.81 on Friday, hitting $125.60. The stock had a trading volume of 16,942 shares, compared to its average volume of 760,482. The company has a current ratio of 1.38, a quick ratio of 1.38 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $7.77 billion, a PE ratio of 224.11, a P/E/G ratio of 1.45 and a beta of 1.27. Molina Healthcare has a 1 year low of $67.56 and a 1 year high of $154.06.
Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, October 31st. The company reported $2.55 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.65 by $0.90. Molina Healthcare had a positive return on equity of 23.01% and a negative net margin of 0.26%. The firm had revenue of $4.70 billion during the quarter, compared to analysts’ expectations of $4.72 billion. During the same period in the previous year, the firm posted ($1.62) EPS. Molina Healthcare’s revenue for the quarter was down 6.6% on a year-over-year basis. Research analysts predict that Molina Healthcare will post 6.69 EPS for the current fiscal year.
Several research firms recently commented on MOH. ValuEngine cut Molina Healthcare from a buy rating to a hold rating in a research note on Thursday. Zacks Investment Research raised Molina Healthcare from a hold rating to a strong-buy rating and set a $155.00 target price for the company in a research note on Tuesday, October 23rd. Morgan Stanley boosted their target price on Molina Healthcare from $178.00 to $184.00 and gave the stock an overweight rating in a research note on Thursday, October 18th. Jefferies Financial Group cut Molina Healthcare from a buy rating to a hold rating and set a $152.00 target price for the company. in a research note on Friday, October 12th. They noted that the move was a valuation call. Finally, Evercore ISI began coverage on Molina Healthcare in a research note on Tuesday, October 9th. They set an in-line rating and a $158.00 target price for the company. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has an average rating of Hold and a consensus target price of $130.62.
In other news, insider Norman Nichols sold 4,501 shares of the company’s stock in a transaction dated Wednesday, August 8th. The stock was sold at an average price of $127.00, for a total transaction of $571,627.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Daniel Cooperman sold 943 shares of the company’s stock in a transaction dated Tuesday, August 14th. The stock was sold at an average price of $133.81, for a total value of $126,182.83. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 9,717 shares of company stock valued at $1,289,932. Insiders own 0.65% of the company’s stock.
About Molina Healthcare
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Further Reading: Can individual investors take part in an IPO?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.